Shares of Inovio Pharmaceuticals (NYSE:INO) were the recipient of a large drop in short interest in the month of January. As of February 14th, there was short interest totalling 21,654,862 shares, a drop of 2.1% from the January 31st total of 21,207,301 shares, AnalystRatings.Net reports. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $3.33 in last session, and closed at $3.42, while the day range of stock is $3.20 – $3.48. The stock showed a positive weekly performance of 17.93%.
Shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) reported fourth quarter 2013 loss of 40 cents per share, wider than the year-ago loss of 36 cents per share but narrower than the Zacks Consensus Estimate of a loss of 46 cents per share. Fourth quarter revenues were $8.4 million, compared to $0.07 million in the year-ago quarter. Revenues surpassed the Zacks Consensus Estimate of $6 million. For 2013, ARIAD reported a loss of $1.49 per share, wider than the year-ago loss of $1.34 per share but narrower than the Zacks Consensus Estimate of a loss of $1.56 per share. Revenues were $45.6 million in 2013 as against $0.6 million in the previous year. Revenues surpassed the Zacks Consensus Estimate of $43 million. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $8.48, in last session and closed at $8.99, by gaining 5.15%. The 52 week range of the stock is $2.15 – $23.00. Company’s market capitalization is $1.67 billion.
Zacks upgraded shares of Gilead Sciences (NASDAQ:GILD) from a neutral rating to an outperform rating in a report released on Wednesday,Analyst Ratings Net reports. Zacks currently has $101.00 price objective on the stock. Gilead Sciences, Inc. (NASDAQ:GILD) stock decreased -0.19% and finished the last session at $83.65. The EPS of the stock remained 1.83. Company’s market capitalization is $128.35 billion.
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) released its Q4 and full year results Thursday. As investors already know, the equity took a hit on the results. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened the session at $6.89, and closed the session at $6.77. The 52 week range of the stock remained $4.05 – $9.25 and the day range was $6.63 – $6.89.
Leave a Reply